In addition to TP53 mutations, BRCA2 (55.3%), NF1 (52.6%), BRCA1 (47.4%), and CDH1 (47.4%) mutations were also commonly detected in ovarian cancer in the present study. Here, CDH1 is linked to ovarian carcinoma.